BluePoint Bioscience is committed to producing monoclonal antibodies using only the highest quality production methods. All antibodies are produced using in-vitro cell culture systems and procedures to ensure antibody consistency and production reproducibility. In-vitro antibody production allows the researcher to control and optimize the culture conditions, and eliminate contaminating endogenous immunoglobulin present in ascites fluid. Subsequent purification of cell culture produced antibody is generally less problematic and more consistent.
For complete details concerning in-vitro monoclonal antibody production services that BluePoint Bioscience has to offer, please contact our project management team.
Phone: 301-874-3981 • E-mail: BluePoint@BluePointBioscience.com